Beam Therapeutics Inc. Share of Subsidiary Earnings

Share of Subsidiary Earnings of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Share of Subsidiary Earnings growth rates and interactive chart.


Highlights and Quick Summary

  • Share of Subsidiary Earnings for the quarter ending September 30, 2022 was $-25.5 Million
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Share of Subsidiary Earnings of Beam Therapeutics Inc.

Most recent Share of Subsidiary Earningsof BEAM including historical data for past 10 years.

Interactive Chart of Share of Subsidiary Earnings of Beam Therapeutics Inc.

Beam Therapeutics Inc. Share of Subsidiary Earnings for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-25.5

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology